In these studies, PD-ligand 1 (PDL1) expression was not shown to be predictive, and investigation on tumor mutation burden (TMB), tumor-infiltrating lymphocytes, and gene expression patterns is now undertaken. The gene discussed is CD274; the disease is neoplasm.